Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Dihydrofolate Reductase anticorps

L’anticorps Lapin Polyclonal anti-Dihydrofolate Reductase a été validé pour WB, IHC (p), IF (p) et FACS. Il convient pour détecter Dihydrofolate Reductase dans des échantillons de Humain.
N° du produit ABIN1387277

Aperçu rapide pour Dihydrofolate Reductase anticorps (ABIN1387277)

Antigène

Voir toutes Dihydrofolate Reductase (DHFR) Anticorps
Dihydrofolate Reductase (DHFR)

Reactivité

  • 53
  • 25
  • 21
  • 2
  • 1
Humain

Hôte

  • 46
  • 10
  • 1
Lapin

Clonalité

  • 42
  • 15
Polyclonal

Conjugué

  • 34
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Dihydrofolate Reductase est non-conjugé

Application

  • 34
  • 19
  • 16
  • 15
  • 10
  • 9
  • 8
  • 6
  • 4
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Flow Cytometry (FACS)
  • Purification

    purified by Protein A and peptide affinity chromatography

    Immunogène

    KLH conjugated synthetic peptide derived from human DHFR

    Isotype

    IgG
  • Indications d'application

    WB (1:100-500),IHC-P (1:100-500),FACS (1:50-200),IF (p) (1:50-200)

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 µg/µL

    Buffer

    Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20 °C for 12 months

    Date de péremption

    12 months
  • Antigène

    Dihydrofolate Reductase (DHFR)

    Autre désignation

    DHFR

    Sujet

    DHFR catalyzes the NADPH-dependent reduction of dihydrofolate to tetrahydrofolate, and is a crucial enzyme for the synthesis of purines, pyrimidines and some amino acids. Inhibition of the activity of this enzyme leads to arrest of DNA synthesis and cell death. Gene expression of methotrexate (MTX)-resistant variants of DHFR in normal hematopoietic cells is a potential strategy to permit administration of larger doses of MTX by alleviating drug toxicity in normal cells and tissues that are drug sensitive.

    Poids moléculaire

    21kDa

    ID gène

    1719

    HGNC

    0

    Pathways

    Mitotic G1-G1/S Phases
Vous êtes ici:
Chat with us!